CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, 1138
N. diseases: 110; N. variants: 40
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Mental Disorders | 0.030 | 1.000 | 3 | 2011 | 2019 | ||||||
|
1.000 | 0.040 | 15 | 78593856 | 3 prime UTR variant | C/T | snv | 0.24 |
|
Respiratory Tract Diseases | 0.700 | 1.000 | 2 | 2015 | 2019 | |||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2019 | 2019 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2019 | 2019 | ||||||
|
0.827 | 0.120 | 15 | 78575140 | intron variant | A/C | snv | 0.32 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.080 | 15 | 78565644 | 5 prime UTR variant | C/G | snv | 0.31 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.080 | 15 | 78565644 | 5 prime UTR variant | C/G | snv | 0.31 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Chemically-Induced Disorders; Mental Disorders | 0.100 | 1.000 | 29 | 2008 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.963 | 27 | 2008 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.963 | 27 | 2008 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.963 | 27 | 2008 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Respiratory Tract Diseases | 0.780 | 0.889 | 9 | 2010 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2010 | 2017 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2010 | 2017 | ||||||
|
0.827 | 0.120 | 15 | 78575140 | intron variant | A/C | snv | 0.32 |
|
Respiratory Tract Diseases | 0.700 | 1.000 | 3 | 2015 | 2017 | |||||||
|
0.851 | 0.080 | 15 | 78565644 | 5 prime UTR variant | C/G | snv | 0.31 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||||
|
0.851 | 0.080 | 15 | 78565644 | 5 prime UTR variant | C/G | snv | 0.31 |
|
Neoplasms | 0.710 | 1.000 | 2 | 2013 | 2017 | |||||||
|
1.000 | 0.080 | 15 | 78591694 | intron variant | CCTT/- | delins | 6.3E-03 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 |